Cargando…
Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome
Background and study aims The World Health Organization criteria for serrated polyposis syndrome (SPS) were established in 2010 and modified in 2019. Neither set of criteria have been validated against genetic markers or proven to be the optimal criteria for defining colorectal cancer risk in patie...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812648/ https://www.ncbi.nlm.nih.gov/pubmed/36618871 http://dx.doi.org/10.1055/a-1958-2529 |
_version_ | 1784863774751064064 |
---|---|
author | McWhinney, Connor D. Lahr, Rachel E. Lee, Christopher J. El-Rahyel, Ahmed Rex, Douglas K. |
author_facet | McWhinney, Connor D. Lahr, Rachel E. Lee, Christopher J. El-Rahyel, Ahmed Rex, Douglas K. |
author_sort | McWhinney, Connor D. |
collection | PubMed |
description | Background and study aims The World Health Organization criteria for serrated polyposis syndrome (SPS) were established in 2010 and modified in 2019. Neither set of criteria have been validated against genetic markers or proven to be the optimal criteria for defining colorectal cancer risk in patients with serrated colorectal lesions. In this study, we sought to gain insight into how frequently the change in SPS criteria in 2019 impacted the diagnosis of SPS. Patients and methods We reviewed 279 patients with SPS diagnosed between 2010 and 2019 using the 2010 criteria (n = 163) or since 2019 using the 2019 criteria (n = 116). We reviewed whether patients in each group met the diagnosis of SPS by the alternative criteria. Results Of those diagnosed using 2010 criteria, 5.5 % did not meet 2019 criteria. Of those diagnosed by 2019 criteria, 10.3 % did not meet 2010 criteria. Conclusions Most patients with SPS in our database met the diagnosis of SPS by both 2010 and 2019 criteria, with only 5 % to 10 % of patients in each cohort not meeting the alternative diagnostic criteria. |
format | Online Article Text |
id | pubmed-9812648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-98126482023-01-05 Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome McWhinney, Connor D. Lahr, Rachel E. Lee, Christopher J. El-Rahyel, Ahmed Rex, Douglas K. Endosc Int Open Background and study aims The World Health Organization criteria for serrated polyposis syndrome (SPS) were established in 2010 and modified in 2019. Neither set of criteria have been validated against genetic markers or proven to be the optimal criteria for defining colorectal cancer risk in patients with serrated colorectal lesions. In this study, we sought to gain insight into how frequently the change in SPS criteria in 2019 impacted the diagnosis of SPS. Patients and methods We reviewed 279 patients with SPS diagnosed between 2010 and 2019 using the 2010 criteria (n = 163) or since 2019 using the 2019 criteria (n = 116). We reviewed whether patients in each group met the diagnosis of SPS by the alternative criteria. Results Of those diagnosed using 2010 criteria, 5.5 % did not meet 2019 criteria. Of those diagnosed by 2019 criteria, 10.3 % did not meet 2010 criteria. Conclusions Most patients with SPS in our database met the diagnosis of SPS by both 2010 and 2019 criteria, with only 5 % to 10 % of patients in each cohort not meeting the alternative diagnostic criteria. Georg Thieme Verlag KG 2023-01-04 /pmc/articles/PMC9812648/ /pubmed/36618871 http://dx.doi.org/10.1055/a-1958-2529 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | McWhinney, Connor D. Lahr, Rachel E. Lee, Christopher J. El-Rahyel, Ahmed Rex, Douglas K. Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome |
title | Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome |
title_full | Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome |
title_fullStr | Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome |
title_full_unstemmed | Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome |
title_short | Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome |
title_sort | impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812648/ https://www.ncbi.nlm.nih.gov/pubmed/36618871 http://dx.doi.org/10.1055/a-1958-2529 |
work_keys_str_mv | AT mcwhinneyconnord impactofchangingdiagnosticcriteriaonthediagnosisofserratedpolyposissyndrome AT lahrrachele impactofchangingdiagnosticcriteriaonthediagnosisofserratedpolyposissyndrome AT leechristopherj impactofchangingdiagnosticcriteriaonthediagnosisofserratedpolyposissyndrome AT elrahyelahmed impactofchangingdiagnosticcriteriaonthediagnosisofserratedpolyposissyndrome AT rexdouglask impactofchangingdiagnosticcriteriaonthediagnosisofserratedpolyposissyndrome |